Overview This page contains the latest trade data of Tetracyclines, derivatives, in bulk, salts. In 2023, Tetracyclines, derivatives, in bulk, salts were the world's 2593rd most traded product, with a total trade of $638M. Between 2022 and 2023 the exports of Tetracyclines, derivatives, in bulk, salts decreased by -25.7%, from $858M to $638M. Trade in Tetracyclines, derivatives, in bulk, salts represent 0.0028% of total world trade.
Tetracyclines, derivatives, in bulk, salts are a part of Antibiotics.
Exports In 2023 the top exporters of Tetracyclines, derivatives, in bulk, salts were China ($373M), Italy ($69.5M), Portugal ($36.9M), Belgium ($25.1M), and Germany ($24.7M).
Imports In 2023 the top importers of Tetracyclines, derivatives, in bulk, salts were United States ($64.2M), India ($62.4M), Italy ($49.2M), Netherlands ($37.5M), and Spain ($31.1M).
Ranking Tetracyclines, derivatives, in bulk, salts ranks 1049th in the Product Complexity Index (PCI).
Description Tetracyclines are a family of broad-spectrum antibiotics which are used to combat a wide variety of bacterial infections. Derivatives of this family include doxycycline and minocycline. Doxycycline is primarily used to treat respiratory tract infections, acne, and chlamydia. Minocycline is used to treat acne, periodontitis, and rheumatoid arthritis.